National Cancer Institute
Cient
National Cancer Institute
Contract Title
Cancer Trials Support Unit
Patient Consenting and Clinical Trials Recruitment (CTR) Services
Period of Performance
August 1, 2022 to July 31, 2027
NAICS Code
541611
Expanding Access to Cancer Trials: Patient Consenting and Recruitment Support for CTSU
Since 2022, EDJ Associates, Inc. has provided critical Patient Consenting and Clinical Trial Recruitment Services for the National Cancer Institute’s Cancer Trials Support Unit (CTSU) helping to bridge the gap between groundbreaking cancer research and patient participation.
The Challenge
EDJ Associates, Inc. Critical Role
EDJ Associates, Inc. ensures Patient Consenting and Clinical Trial Recruitment Services materials meet the highest standards by evaluating CTSU content across multiple platforms for consistency, usability, and audience appropriateness. The team also provides consultation to other NCI contractors on patient consenting and recruitment strategies, extending their impact across the entire clinical trials ecosystem. EDJ Associates, Inc. specialized team develops comprehensive strategies to facilitate patient consenting and clinical trial recruitment across diverse audiences:
- Multi-Channel Communications: Creates targeted email campaigns, newsletters, webinars, videos, and social media content to reach clinicians, patient advocates, and the general public
- Site Support Materials: Develops customized initiation packets for each CTSU study, providing clear guidance on study conduct and management for research sites
- Language Access: Provides Spanish translations for all informed consent documents and translates materials into the top 10 most frequently spoken languages in the US, ensuring diverse populations can participate
- Strategic Promotion: Develops tailored materials for high-visibility initiatives like precision medicine trials, identifying optimal distribution methods for maximum impact
Impact
EDJ Associates, Inc. Patient Consenting and Clinical Trial Recruitment Services enable more patients to discover and participate in clinical trials while helping healthcare providers better understand and promote NCI studies. By breaking down communication barriers and creating accessible consenting materials, EDJ Associates, Inc. directly contributes to advancing cancer treatment through increased trial participation and improved patient outcomes.
Key Differentiators
Successfully managed $7.4M contract with detailed expense tracking by task area and NCI Program/Division, maintaining monthly, quarterly, annual, and contract-to-date financial reporting with funds tracking for provided, expended, and remaining balances.
Demonstrated exceptional capability in managing complex, multi-faceted government contracts requiring specialized expertise in medical communications, regulatory compliance, translation services, and stakeholder engagement within the highly regulated clinical trials environment, directly supporting NCI’s mission to advance cancer research through enhanced clinical trial awareness and participation.